Fluconazole kills fungi by blocking the production of a critical component in their cell membranes. It’s one of the most widely prescribed antifungal medications in the world, used for everything from a single-dose vaginal yeast infection treatment to weeks-long therapy for serious systemic infections. Understanding how it works helps explain why it’s so effective against certain fungi, why it sometimes fails, and why it interacts with so many other medications.
How Fluconazole Attacks Fungal Cells
Fungal cells rely on a molecule called ergosterol to keep their cell membranes intact and functional. Ergosterol does for fungi what cholesterol does for human cells: it maintains structure, controls what passes in and out, and keeps the cell alive. Fluconazole targets the enzyme responsible for converting a precursor molecule into ergosterol. Without that enzyme working, fungi can’t build proper membranes.
The result is straightforward. As ergosterol production stalls, the fungal membrane becomes increasingly porous. Essential contents leak out, the cell can no longer regulate its internal environment, and it eventually ruptures and dies. Human cells don’t use ergosterol or this particular enzyme, which is why fluconazole can kill fungi without directly damaging your own tissue.
How Quickly It Gets Into Your System
Fluconazole is unusually well absorbed for an antifungal. More than 90% of an oral dose reaches your bloodstream, which is why the pill form works nearly as well as an IV drip. Plasma concentrations peak roughly one to two hours after you take it, so the drug gets to work fast.
What really sets fluconazole apart is how long it stays active. Its elimination half-life is approximately 30 hours, with a range of 20 to 50 hours depending on the person. That long half-life is the reason a single 150 mg pill can clear a straightforward vaginal yeast infection: the drug lingers at effective levels for days after just one dose. For more serious infections, this pharmacokinetic profile means once-daily dosing is sufficient.
About 80% of the drug leaves your body unchanged through the kidneys. This means kidney function has a major influence on how long fluconazole stays in your system. People with reduced kidney function clear the drug more slowly, which can require dose adjustments.
Which Fungi It Works Against
Fluconazole’s effectiveness is limited to yeasts and a few specific endemic fungi. It works well against most Candida species (the organisms behind yeast infections, oral thrush, and candidemia) and Cryptococcus (the cause of a dangerous form of meningitis in immunocompromised patients). It also has activity against the fungi responsible for histoplasmosis, blastomycosis, and coccidioidomycosis, which are regional infections found in certain parts of the Americas.
There are notable gaps. Candida glabrata has reduced susceptibility, and Candida krusei is inherently resistant. Mold infections, including aspergillosis, don’t respond to fluconazole at all. This matters clinically because if your infection involves one of these resistant organisms, fluconazole simply won’t work regardless of the dose.
How Fungi Develop Resistance
Resistance to fluconazole is a growing concern, particularly in hospital settings and in patients who take the drug for extended periods. Fungi have evolved several strategies to survive despite fluconazole exposure.
The most common mechanism involves efflux pumps, which are molecular transport systems embedded in the fungal cell membrane. These pumps actively push fluconazole back out of the cell before it can accumulate to lethal concentrations. Genetic mutations can ramp up the production of these pumps, making the fungal cell increasingly efficient at expelling the drug. Mutations in the genes that regulate two major families of efflux pumps have been well documented in Candida albicans.
Fungi can also mutate the target enzyme itself, changing its shape just enough that fluconazole no longer binds effectively while the enzyme continues to produce ergosterol. Some strains even increase production of the target enzyme, essentially overwhelming the drug’s ability to shut down the pathway.
Why It Interacts With So Many Medications
Fluconazole is a strong inhibitor of one liver enzyme system and a moderate inhibitor of two others. These enzyme systems are responsible for breaking down a wide range of common medications. When fluconazole blocks them, those other drugs aren’t metabolized as quickly, so their levels in your blood can climb to potentially dangerous concentrations.
The practical impact is significant. Blood thinners like warfarin can become dangerously more potent. Certain cholesterol-lowering statins may accumulate and increase the risk of muscle damage. Some sedatives, seizure medications, and immunosuppressants are also affected. Even a single 150 mg dose can influence these enzyme systems for days given fluconazole’s long half-life, so interactions can occur even with short courses.
Common and Serious Side Effects
Most people tolerate fluconazole well, especially at lower doses. The most frequently reported side effects are nausea, vomiting, and headache. These tend to be mild and often resolve without stopping the medication.
Liver effects deserve attention. Temporary, mild-to-moderate elevations in liver enzymes show up in about 5% of patients. More significant elevations, at eight times the normal upper limit, occur in roughly 1% and represent the most common reason treatment gets stopped early. Clinically apparent liver injury from fluconazole is rare, but when it happens it typically appears within the first few weeks of therapy. It may come with fever, rash, and signs of an allergic-type reaction.
Fluconazole During Pregnancy
The FDA’s labeling recommends against using fluconazole during pregnancy except for severe or life-threatening fungal infections. However, the level of risk depends heavily on the dose and duration.
A single 150 mg dose, the standard treatment for a vaginal yeast infection, does not appear to meaningfully increase the risk of miscarriage or birth defects based on the available evidence. The FDA stated in 2019 that existing studies do not provide definitive evidence of increased miscarriage risk at this dose. Some research suggests a small increase in the chance of heart defects or other structural problems with doses between 150 and 300 mg during the first trimester, though the evidence isn’t conclusive.
High-dose, prolonged use is a different story. A pattern of birth defects involving the head, face, bones, and heart has been reported in children born to women who took 400 to 1,200 mg daily for many weeks during pregnancy to treat severe infections. For context, about 3% of all babies are born with some type of birth defect regardless of medication exposure, so researchers look for patterns above that baseline rate.